Water Vapour Therapy (REZUM) is a minimally invasive procedure for men looking to treat their Benign Prostatic Hyperplasia (BPH). It uses water vapour to reduce the size of the prostate and provide lasting symptom relief from BPH symptoms without invasive surgery or the potential side effects of prescription drugs.
Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland. Enlarged prostates affect at least half of men over 60 years of age. Many men with enlarged prostates (Benign Prostatic Hyperplasia, BPH) find their lives drastically changed after the lower urinary tract symptoms (LUTS), such as urgency or frequency of urination, incontinence, or incomplete voiding, sets in. BPH can cause other problems if untreated, such as kidney, bladder and urinary tract infections, bladder stones & impaired kidneys functions.
During the Rezum Therapy, water vapour is released throughout the targeted prostate tissue. When the steam contacts the tissue and turns back into water, all the stored energy is released, killing the excess prostate cells and causing it to shrink and enlarge the opening, so that urine can flow freely. The procedure involves injecting steam at certain points in the prostate using a special device. The procedure is quick, relatively painless and can be completed within 10 minutes with Anaesthesia. A urinary catheter will be inserted for one week to allow you to urinate while waiting for the post operative inflammation to subside.
The number of water vapor
treatments varies depending on the size
of the prostate. The procedure is done during one
appointment.
The images are intended to show how the procedure works, not
to
provide an exact representation of patient results.
All treatments have inherent and associated risks. The Rezūm System is intended to relieve symptoms and obstructions and reduce prostate tissue associated with BPH. It is indicated for men ≥ 50 years of age with a prostate volume 30cm3 ≤ 80cm3.
The Rezūm System is also indicated for treatment of prostate with hyperplasia of the central zone and/or a median lobe. Potential risks include but are not limited to painful urination (dysuria), blood in the urine (hematuria), blood in the semen (hematospermia), decrease in ejaculatory volume, suspected urinary tract infection (UTI), and urinary frequency, retention, or urgency. These are usually temporary. Patients should talk with their doctor about benefits and risks before moving forward with any treatment option.